Last reviewed · How we verify
VCL-IPT1
At a glance
| Generic name | VCL-IPT1 |
|---|---|
| Sponsor | Vical |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pandemic Influenza Plasmid DNA Vaccines (Needle-Free) (PHASE1)
- Pandemic Influenza Plasmid DNA Vaccines (Needle) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- VCL-IPT1 CI brief — competitive landscape report
- VCL-IPT1 updates RSS · CI watch RSS
- Vical portfolio CI